An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects - Trial 2016-004945-10
Access comprehensive clinical trial information for 2016-004945-10 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Co., ltd and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-004945-10
Trial Details
EU Clinical Trials Register • 2016-004945-10
An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
Study Focus
Sponsor & Location
Eisai Co., ltd
Eisai Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Number of participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2016-004945-10
Non-Device Trial